The U.S. Federal Menthol Ban: a Critical Step Toward Health Equity for African Americans

Despite longstanding evidence of the disproportionate burden menthol cigarettes pose to Black Americans, the U.S. Food and Drug Administration's (FDA) proposed federal ban has faced consistent delays. Menthol is associated with an increased risk of addiction, fewer quit attempts, and disproportionate rates of smoking-related illness and death among Black Americans. While states like Massachusetts and California have taken steps to implement bans, the U.S. federal government has yet to act. These delays are a public health failure that perpetuates racial health disparities. This paper explores the historical targeting of Black communities by the tobacco industry and highlights the complex responses to the potential ban from those in Black communities. Despite mixed public opinion, the evidence is clear that a federal menthol ban, combined with equitable culturally tailored cessation resources, can save lives and address disproportionate tobacco-related health disparities.